Analysts Set Expectations for Cronos Group FY2024 Earnings

Cronos Group Inc. (NASDAQ:CRON) – Stock analysts at Roth Capital increased their FY2024 earnings per share (EPS) estimates for Cronos Group in a note issued to investors on Wednesday, November 13th. Roth Capital analyst W. Kirk now forecasts that the company will post earnings of ($0.06) per share for the year, up from their prior forecast of ($0.08). The consensus estimate for Cronos Group’s current full-year earnings is ($0.05) per share.

Cronos Group Price Performance

CRON stock opened at $2.07 on Friday. The company’s 50-day moving average price is $2.17 and its two-hundred day moving average price is $2.35. Cronos Group has a 12 month low of $1.85 and a 12 month high of $3.14.

Institutional Trading of Cronos Group

Several large investors have recently made changes to their positions in the company. ClariVest Asset Management LLC lifted its stake in shares of Cronos Group by 2.8% in the 2nd quarter. ClariVest Asset Management LLC now owns 273,184 shares of the company’s stock valued at $637,000 after acquiring an additional 7,362 shares during the last quarter. Toronto Dominion Bank raised its holdings in shares of Cronos Group by 204.8% during the first quarter. Toronto Dominion Bank now owns 17,054 shares of the company’s stock valued at $45,000 after purchasing an additional 11,459 shares during the period. National Bank of Canada FI boosted its holdings in Cronos Group by 1,094.4% in the second quarter. National Bank of Canada FI now owns 15,169 shares of the company’s stock worth $35,000 after acquiring an additional 13,899 shares in the last quarter. Cedar Wealth Management LLC grew its position in Cronos Group by 65.4% in the 2nd quarter. Cedar Wealth Management LLC now owns 37,935 shares of the company’s stock valued at $88,000 after purchasing an additional 15,000 shares during the period. Finally, Quantbot Technologies LP bought a new stake in Cronos Group during the 3rd quarter valued at $37,000. Institutional investors and hedge funds own 8.71% of the company’s stock.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.